MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Efficacy And Safety of Fecal Microbiota Transplant for Parkinson’s Disease: A Systematic Review And Meta-Analysis

    A. Koppanatham, A. Bin Gulzar, M. Ammar Arshad, E. de Farias, V. Suresh, M. Tariq, R. Vasireddy, T. Varkey (Lahore, Pakistan)

    Objective: To evaluate the efficacy and safety of Fecal Microbiota Transplantation (FMT) in patients with Parkinson’s disease (PD). Background: FMT is a novel therapy for…
  • 2025 International Congress

    Broad spectrum local field potential activities as a novel biomarker for adaptive deep brain stimulation

    CH. Tai, YC. Lin, WH. Hu, MT. Hsu, SH. Tseng (Hsinchu, Taiwan)

    Objective: This study aims to evaluate the wider frequency range (1-200 Hz) LFPs as the novel neural biomarkers for adaptive DBS. In parkinsonism rats, we…
  • 2025 International Congress

    Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers

    H. Khelifa, A. R. Al-Ihribat, H. Smeda, A. Hendawy, A. Abunamoos (Oran, Algeria)

    Objective: To update the available data on the prevalence of cancer among patients with Parkinson’s Disease (PD) and the prevalence of PD among cancer patients…
  • 2025 International Congress

    Clinical and neuro-imaging predictors of falls in PLA2G6-related Parkinsonism: a retrospective study

    C. Chen, Y. Sun, H. Dai, F. Liu, . Jun, X. Liu, J. Wang (Shanghai, China)

    Objective: This study investigates clinical and neuroimaging predictors of recurrent falls and gait disturbances in PLA2G6-related Parkinsonism. Background: PLA2G6-related Parkinsonism is characterized by dystonia-parkinsonism, cerebellar…
  • 2025 International Congress

    A Case of Autosomal Dominant Hypocalcemia Presenting with Parkinsonism and Widespread Brain Calcifications

    J. Barnes, M. Boca (Bristol, United Kingdom)

    Objective: To describe a case of CASR mutation-related hypocalcemia presenting with progressive movement disorder, cognitive decline, and widespread brain calcifications, illustrating the overlap between metabolic and neurodegenerative disorders.…
  • 2025 International Congress

    Anti Yo-1 Antibody Syndrome: A Case Study of a Paraneoplastic Syndrome Mimicking Atypical Parkinsonism

    R. Rodriguez (San Jose, Costa Rica)

    Objective: To report the case of a patient with anti Yo-1 antibody syndrome mimicking clinically and radiologically as an atypical parkinsonism. Background: The anti Yo-1…
  • 2025 International Congress

    Rapid Onset Progressive Dystonia with Parkinsonism

    D. Nguyen, R. Parihar (Bronx, USA)

    Objective: To illustrate a case of a patient presenting with oromandibular dystonia with blepharospasm (Meige syndrome) and progressing to a segmental dystonia with parkinsonism. This…
  • 2025 International Congress

    Novel Heterozygous Variant in DCTN1 Associated with Perry Syndrome

    D. Yang, Y. Zhang, Z. Cen, W. Luo (Hangzhou, China)

    Objective: To identify novel mutations in DCTN1 associated with autosomal dominant Perry syndrome and investigate their potential pathogenic mechanisms. Background: Perry syndrome is a neurodegenerative…
  • 2025 International Congress

    The Clinicoradiological profile of patients with Osmotic Demyelination Syndrome and Movement Disorders

    D. Dutta, H. Kumar, J. Ganguly, S. Mukherjee (Kolkata, India)

    Objective: This study aims to characterize clinicoradiological features and outcomes in patients of Osmotic Demyelination Syndrome(ODS) presenting with movement disorders(MD). Background: ODS includes central pontine…
  • 2025 International Congress

    Protective effects of Hesperidin loaded polymeric nanoparticles on the progression of MPTP Induced Parkinson’s disease via targeting GPR43/NLRP3 signaling pathway: in vitro and in vivo studies

    M. Singh (Prayagraj, India)

    Objective: Emphasizing the G protein-coupled receptor 43 (GPR43) and the NLRP3 signaling pathway in both in vitro and in vivo models, this work studies the…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley